UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
2017 · Neoplasia · 6,454 citations
https://doi.org/10.1016/j.neo.2017.05.002
S
Sooryanarayana Varambally
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
410
Papers
42.8K
Citations
75
h-index
140
i10-index
Sooryanarayana Varambally is an academic researcher from University of Alabama at Birmingham Hospital. The author has contributed to research in topics: Epigenetics and DNA Methylation & Prostate Cancer Treatment and Research & RNA modifications and cancer. The author has an h-index of 75, co-authored 349 publications.
ORCID: 0000-0002-2277-1127Papers by this author
worksUALCAN: An update to the integrated cancer data analysis platform
2022 · Neoplasia · 2,398 citations
https://doi.org/10.1016/j.neo.2022.01.001
Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
2008 · Neoplasia · 693 citations
https://doi.org/10.1593/neo.07822
Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers
2019 · Nature Communications · 556 citations
https://doi.org/10.1038/s41467-019-13528-0
Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
2010 · Neoplasia · 347 citations
https://doi.org/10.1593/neo.10726
Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior
2017 · Matrix Biology · 221 citations
https://doi.org/10.1016/j.matbio.2017.09.001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat